National Center for Complementary & Alternative Medicine; Notice of Closed Meeting, 14823 [E8-5467]
Download as PDF
<![CDATA[
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 54 / Wednesday, March 19, 2008 / Notices
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters to be Discussed: The topics for the
Subcommittee meeting will include a Review
of Individual Dose Reconstructions and
future Subcommittee Plans and Actions. The
agenda for the Advisory Board meeting
includes: NIOSH Program Status Report
Update; Special Exposure Class (SEC)
Petition Evaluation Reports for: Texas City
Chemicals, Inc., SAM Laboratories, Kellex/
Pierpont, Massachusetts Institute of
Technology, Area IV of the Santa Susana
Field Laboratory, Horizons, Inc., and NUMEC
Parks; Quality assurance and quality control
processes by NIOSH; Ethics training for
Board members; Procedures Work Group:
summary report and full presentation on new
matrix format; SEC Petition Status Updates:
Sandia National Laboratory-Livermore,
Chapman Valve, Hanford, Blockson,
Bethlehem Steel; Department of Labor (DOL)
Update; Department of Energy (DOE) Update;
Work Group reports; Subcommittee on Dose
Reconstruction Report; Board Future Plans
and Schedules.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted
according the policy provided below. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public Web site. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public comment;
(c) A statement such as outlined in (a) above
will also appear with the agenda for a Board
Meeting when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that
announces Board and Subcommittee
meetings. (3) If an individual in making a
statement reveals personal information (e.g.,
medical information) about themselves that
information will not usually be redacted. The
NIOSH FOIA coordinator will, however,
review such revelations in accordance with
the Freedom of Information Act and the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share
information with the Board but objects to
doing so in a public forum, the DFO will
work with that individual, in accordance
VerDate Aug<31>2005
16:50 Mar 18, 2008
Jkt 214001
with the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Christine Branche, PhD, Executive Secretary,
NIOSH, CDC, 395 E Street, SW., Suite 9200,
Washington, DC 20201, Telephone (513)
533–6800, Toll Free 1–(800) 35–NIOSH, Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 12, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–5496 Filed 3–18–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Practice-Based
Research Networks.
Date: April 21, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Administrator, Office
of Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–402–1030,
donzel@mail.nih.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
14823
Dated: March 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5467 Filed 3–18–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Commission on Digestive
Diseases.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National
Commission on Digestive Diseases.
Date: May 16, 2008.
Time: 4 p.m. to 7 p.m.
Agenda: Update on burden of disease
report; overview of Commission and key
elements of final report and general
discussion. Pre-registration is required;
instructions will be available on the
Commission’s Web site at https://www2.
niddk.nih.gov/AboutNIDDKlCommittees
AndWorkingGroups/NCDD/default.htm.
Place: Westin San Diego, 400 West
Broadway, Topaz Room, San Diego, CA
92101.
Contact Person: Stephen P. James,
MD, Director, Division of Digestive
Diseases & Nutrition, National Institute
of Diabetes and Digestive and Kidney
Diseases, NIH, 6707 Democracy Blvd.,
Rm. 677, Bethesda, MD 20892–5450,
301–594–7680,
natlcommdd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5463 Filed 3–18–08; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 73, Number 54 (Wednesday, March 19, 2008)]
[Notices]
[Page 14823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5467]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Alternative Medicine Special Emphasis Panel; Practice-Based Research
Networks.
Date: April 21, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Laurie Friedman Donze, PhD, Scientific Review
Administrator, Office of Scientific Review, National Center for
Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd.,
Suite 401, Bethesda, MD 20892, 301-402-1030, donzel@mail.nih.gov.
Dated: March 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-5467 Filed 3-18-08; 8:45 am]
BILLING CODE 4140-01-M
